About Javeri Equity Derivatives Mutual Funds IPO Corporate Info Research Contact Us
Mutual Funds
Mutual Funds
Fund Profile
Scheme Profile
Daily NAV
Historical NAV
Category Returns
Dividend Details
Fund Ranking
MF Activities
All Holdings
What's In / What's Out
MF Trends
MF Tools
  Home   >   MUTUAL FUND  >  MUTUAL FUNDS  > SCHEME PROFILE
SCHEME PROFILE      
AMC : Category : Scheme :
Tata India Pharma & Healthcare Fund(G)-Direct Plan
TypeInvestment In% of NAVNo. of sharesValue (Rs cr)
Domestic EquitiesSUN PHARMACEUTICAL INDUSTRIES LTD11.6361854300143.3174
Domestic EquitiesAPOLLO HOSPITALS ENTERPRISE LTD6.215111125576.5490
Domestic EquitiesCIPLA LTD5.831149000071.8193
Domestic EquitiesAUROBINDO PHARMA LTD5.732261510070.6012
Domestic EquitiesDIVI LABORATORIES LTD5.634910496569.4029
Domestic EquitiesFORTIS HEALTHCARE LTD4.903685510060.3957
Domestic EquitiesLUPIN LTD4.819930324059.3653
Domestic EquitiesASTER DM HEALTHCARE LTD4.345795699153.5245
Domestic EquitiesWOCKHARDT LTD3.270127487140.2768
Domestic EquitiesDR REDDYS LABORATORIES LTD3.165031155538.9818
Domestic EquitiesALKEM LABORATORIES LTD3.11497524938.3657
Domestic EquitiesHEALTHCARE GLOBAL ENTERPRISES LTD2.933566612136.1304
Domestic EquitiesAJANTA PHARMA LTD1.93139473723.7866
Domestic EquitiesMETROPOLIS HEALTHCARE LTD1.863813663622.9562
Domestic EquitiesTORRENT PHARMACEUTICALS LTD1.82807092122.5153
Domestic EquitiesKRISHNA INSTITUTE OF MEDICAL SCIENCES LTD1.819232745222.4059
Domestic EquitiesMEDI ASSIST HEALTHCARE SERVICES LTD1.683841867020.7388
Domestic EquitiesFDC LTD1.679447128320.6846
Domestic EquitiesDR. LAL PATH LABS LTD1.65647321120.4010
Domestic EquitiesIPCA LABORATORIES LTD1.647914245220.2966
Domestic EquitiesINDOCO REMEDIES LTD1.357566699216.7202
Domestic EquitiesJUPITER LIFE LINE HOSPITALS LTD1.265310638915.5839
Domestic EquitiesDR. AGARWALS HEALTH CARE LTD1.251045518715.4081
Domestic EquitiesAKUMS DRUGS AND PHARMACEUTICALS LTD1.193925735214.7051
Domestic EquitiesCOROMANDEL INTERNATIONAL LTD1.11536000013.7364
Domestic EquitiesZYDUS LIFESCIENCES LTD1.036613728712.7677
Domestic EquitiesSANOFI INDIA LTD0.96351916411.8673
Domestic EquitiesAMI ORGANICS LTD0.955010000011.7630
Domestic EquitiesMEDPLUS HEALTH SERVICES LTD0.932211880811.4816
Domestic EquitiesMANKIND PHARMA LTD0.83044144610.2276
Domestic EquitiesSANOFI CONSUMER HEALTHCARE INDIA LTD0.81981916410.0967
Domestic EquitiesPROCTER & GAMBLE HEALTH LTD0.7467160009.1968
Domestic EquitiesGLAXOSMITHKLINE PHARMACEUTICALS LTD0.6585245888.1106
Domestic EquitiesORCHID PHARMA LTD0.58711150007.2306
Domestic EquitiesSYNGENE INTERNATIONAL LTD0.56191070466.9211
Domestic EquitiesINVENTURUS KNOWLEDGE SOLUTIONS LTD0.5103417426.2847
Domestic EquitiesDEEPAK NITRITE LTD0.2948179093.6307
Domestic EquitiesLAXMI DENTAL LTD0.0447143570.5509
Total 90.8361 1118.7980
Cash & Cash Equivalents and Net AssetsCASH / NET CURRENT ASSET8.9201 109.8660
Cash & Cash Equivalents and Net AssetsA) REPO0.2438 3.0025
Total 9.1639 112.8685
 
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA
Publishing of investor charter information | Annexure A – Investor charter of brokers |
Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP
Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.